Locus coeruleus intensity as a marker of early-stage Alzheimer’s disease: associations with plasma pTau 217 and memory
Quiring M, Shuai Y, Zhao W, Alitin JPM, Kapoor A, Engstrom AC, Joyce JL, Iyengar P et al.. medRxiv, 2026-10-09
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
INTRODUCTION The locus coeruleus (LC) is one of the earliest sites of Alzheimer’s disease (AD) pathophysiological changes. LC magnetic resonance imaging (MRI) intensity may reflect effects of AD pathophysiology on the LC, providing a biomarker of early-stage AD. This study examined relationships among MRI-derived LC intensity, plasma phosphorylated tau 217 (pTau 217 ), and memory in older adults without dementia. METHODS Independently living adults aged 59–89 years ( N = 163) underwent neuropsychological assessment and T1-weighted fast spin-echo MRI. We quantified a bilateral LC contrast ratio relative to a pontine reference region, averaged across axial slices. Plasma pTau 217 was measured using the Quanterix ALZpath p-Tau217 Advantage PLUS assay. For a subset ( n = 127), a memory composite score was calculated. RESULTS After adjustment for age, sex, and APOE ɛ4 status, lower LC intensity was associated with higher plasma pTau 217 concentrations (β = −0.17, P = .02). Each 1- SD decrease in LC intensity was associated with 53% higher odds of pTau 217 positivity ( P = .03). In models additionally adjusted for education, a significant LC × pTau 217 interaction for memory (β = −0.18, P = .009) indicated that lower LC intensity was associated with worse memory at low ( P = .01), but not high ( P = .64) pTau 217 levels. DISCUSSION These findings support MRI-derived LC intensity as a marker of early AD-related processes and suggest that LC intensity may provide complementary information not captured by plasma pTau 217 alone. Longitudinal studies are warranted to determine how these relationships change across the early stages of AD.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Quiring, M., Shuai, Y., Zhao, W., Alitin, J. P. M., Kapoor, A., Engstrom, A. C., et al. (2026). Locus coeruleus intensity as a marker of early-stage Alzheimer’s disease: associations with plasma pTau 217 and memory. medRxiv. https://doi.org/10.64898/2026.10.07.26364896
Vancouver
Quiring M, Shuai Y, Zhao W, Alitin JPM, Kapoor A, Engstrom AC, et al. Locus coeruleus intensity as a marker of early-stage Alzheimer’s disease: associations with plasma pTau 217 and memory. medRxiv. 2026. doi:10.64898/2026.10.07.26364896.
BibTeX
@article{quiring2026-1d4e0089,
author = {Quiring, M. and Shuai, Y. and Zhao, W. and Alitin, J. P. M. and Kapoor, A. and Engstrom, A. C. and Joyce, J. L. and Iyengar, P. and others},
title = {{Locus coeruleus intensity as a marker of early-stage Alzheimer’s disease: associations with plasma pTau 217 and memory}},
journal = {medRxiv},
year = {2026},
doi = {10.64898/2026.10.07.26364896},
url = {https://doi.org/10.64898/2026.10.07.26364896}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- RESULTS After adjustment for age, sex, and APOE ɛ4 status, lower LC intensity was associated with higher plasma pTau 217 concentrations (β = −0.17, P = .02).
- Each 1- SD decrease in LC intensity was associated with 53% higher odds of pTau 217 positivity ( P = .03).
- In models additionally adjusted for education, a significant LC × pTau 217 interaction for memory (β = −0.18, P = .009) indicated that lower LC intensity was associated with worse memory at low ( P = .01), but not high ( P = .64) pTau 217 levels.
- DISCUSSION These findings support MRI-derived LC intensity as a marker of early AD-related processes and suggest that LC intensity may provide complementary information not captured by plasma pTau 217 alone.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designlongitudinal study
- Participants163
- Evidence strengthModerate
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 44 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 27 of the 62 points we could judge it on, which is 44 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 163 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 27 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 27 of the 62 points we could judge it on is 44 out of 100. |
| Total | 44 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “p-tau217”
692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.